Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy Additional analysis of week 36 data from Phase 2b ORIGIN study show atacicept 150mg reduces serum...
Source: marketscreener.com